Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SEQUENT SCIENTIFIC Gains 10%; BSE HEALTHCARE Index Down 0.4%
Thu, 11 Jul 13:12

SEQUENT SCIENTIFIC Gains 10%; BSE HEALTHCARE Index Down 0.4%Image source: DNY59/www.istockphoto.com

SEQUENT SCIENTIFIC share price has zoomed 10% and is presently trading at Rs 138.0.

Meanwhile, the BSE HEALTHCARE index is at 38,437.4 (down 0.4%).

Among the top gainers in the BSE HEALTHCARE index today are SUVEN PHARMACEUTICALS (up 4.7%) and ALEMBIC PHARMA (up 2.9%).

Cadila Healthcare (down 1.6%) and AJANTA PHARMA (down 1.6%) are among the top losers today.

Over the last one year, SEQUENT SCIENTIFIC has moved up from Rs 87.4 to Rs 138.0, registering a gain of Rs 50.6 (up 57.9%).

On the other hand, the BSE HEALTHCARE index has moved up from 25,922.2 to 38,437.4, registering a gain of 48.3% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Glenmark Pharma (up 107.9%), Lupin (up 101.8%) and Cadila Healthcare (up 99.9%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 79,796.5 (down 0.2%).

The top losers among the BSE Sensex today are Nestle (down 1.8%) and NTPC (down 1.5%). The most traded stocks in the BSE Sensex are Tata Steel and Power Grid Corp..

In the meantime, NSE Nifty is at 24,297.9 (down 0.1%). Nestle and NTPC are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,344.2 to 79,796.5, registering a gain of 14,452.4 points (up 22.1%).

SEQUENT SCIENTIFIC Financial Update...

SEQUENT SCIENTIFIC net profit grew 101.4% YoY to Rs 13 million for the quarter ended March 2024, compared to a loss of Rs 924 million a year ago. Net sales declined 1.5% to Rs 3,612 million during the period as against Rs 3,667 million in January-March 2023.

For the year ended March 2023, SEQUENT SCIENTIFIC reported 372.5% decrease in net profit to Rs -1,220 million compared to net profit of Rs 448 million during FY22. Revenue of the company grew 0.6% to Rs 14,209 million during FY23.

The current Price to earnings ratio of SEQUENT SCIENTIFIC, based on rolling 12 month earnings, stands at -116.3.


Equitymaster requests your view! Post a comment on "SEQUENT SCIENTIFIC Gains 10%; BSE HEALTHCARE Index Down 0.4%". Click here!